BlackRock, Inc. 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 2,779,452 5.600% | -1,047,771 (-27.38%) | Filing |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 3,827,223 7.800% | 0 (Unchanged) | Filing |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 3,827,223 7.800% | 1,924,086 (+101.10%) | Filing |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 1,903,137 4.200% | -1,301,100 (-40.61%) | Filing |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 3,204,237 7.800% | 208,222 (+6.95%) | Filing |
| 2021-01-29 5:23 pm Purchase | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 2,996,015 7.500% | 104,679 (+3.62%) | Filing |